CEL Celadon Pharmaceuticals Plc

TIDMSWC

RNS Number : 3928E

Summerway Capital PLC

27 February 2020

27 February 2020

Summerway Capital plc

("Summerway" or the "Company")

Results of Annual General Meeting

Following the Annual General Meeting of the Company, which was held earlier today, the Board is pleased to announce that all ordinary and special resolutions set out in the Notice of Annual General Meeting were duly passed.

Details of the number of proxy votes cast for, against and withheld on the resolutions will be published on the Company's website at https://www.summerwaycapital.co.uk/rns .

Enquiries:

 
 Summerway Capital 
 Mark Farmiloe                                  020 7440 7520 
 
 
   N+1 Singer (Nominated Adviser and Broker) 
 Sandy Fraser / Lauren Kettle                   020 7496 3000 
 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGTRMITMTJTBLM

(END) Dow Jones Newswires

February 27, 2020 10:00 ET (15:00 GMT)

Grafico Azioni Celadon Pharmaceuticals (LSE:CEL)
Storico
Da Mar 2024 a Apr 2024

Grafico Azioni Celadon Pharmaceuticals (LSE:CEL)
Storico
Da Apr 2023 a Apr 2024